In a quality management model, which entity does NOT receive data about a surgical incident?

In the context of a quality management model, the Pharmacy and Therapeutics Committee primarily focuses on the management of medications and therapeutic protocols within a healthcare facility. Their responsibilities include reviewing drug formulary, managing pharmaceutical care, and addressing medication-related issues. While they play an essential role in patient safety and medication management, they typically do not directly deal with surgical incidents or outcomes.

In contrast, entities such as the Credentials Committee, Risk Management Program, and Tissue Committee are directly involved in monitoring and evaluating surgical incidents. The Credentials Committee assesses the qualifications of healthcare professionals, which can include evaluating incidents related to their surgical practices. The Risk Management Program is specifically designed to address and analyze incidents that pose risks to patients, including surgical errors, to improve overall safety measures. The Tissue Committee focuses on the handling and management of tissues used in surgeries, which clearly aligns with surgical incident oversight.

Thus, the Pharmacy and Therapeutics Committee is the entity that does not receive data about surgical incidents as its role is more aligned with drug-related considerations rather than surgical quality and safety.